Primary Job Title Co-Founder, CEO & Director Primary Organization 
PaxVax
Location Menlo Park, California, United States Regions San Francisco Bay Area, Silicon Valley, West Coast Gender Male
Mr. Kelley co-founded PaxVax in early 2007 and serves as the Company’s Chief Executive Officer and Executive Chairman.
Mr. Kelley brings to PaxVax thirty years of experience in biotechnology (IntraBiotics, Integrated Genetics), venture capital (K2 BioVentures, Latterell Venture Partners, Institutional Venture Partners), and strategic management
(McKinsey & Company).
During his career, Mr. Kelley has funded 36 early stage biotechnology and medical device companies, fifteen of which became public. As founder/CEO and Chairman of IntraBiotics Pharmaceuticals, Inc., he raised over $200M and took the company public in 2000 (NASDAQ: IBPI). Mr. Kelley also serves as Chairman of the Board for Halozyme (NASDAQ: HALO) and Fluxion Biosystems.
Mr. Kelley earned an M.B.A. from Stanford University and a B.A. in Biochemical Sciences from Harvard University.
